Could Benitec Biopharma Limited – American Depositary SH (NASDAQ:BNTC) Go Down After Its Newest Short Interest Report?

May 18, 2018 - By Samual Williams

Benitec Biopharma Limited (NASDAQ:BNTC) Logo

The stock of Benitec Biopharma Limited – American Depositary SH (NASDAQ:BNTC) registered a decrease of 14.08% in short interest. BNTC’s total short interest was 65,900 shares in May as published by FINRA. Its down 14.08% from 76,700 shares, reported previously. With 8,800 shares average volume, it will take short sellers 8 days to cover their BNTC’s short positions. The short interest to Benitec Biopharma Limited – American Depositary SH’s float is 1.06%.

The stock decreased 3.45% or $0.09 during the last trading session, reaching $2.52. About 17,764 shares traded or 42.19% up from the average. Benitec Biopharma Limited (NASDAQ:BNTC) has risen 22.31% since May 18, 2017 and is uptrending. It has outperformed by 10.76% the S&P500.

Benitec Biopharma Limited, a biotechnology company, develops treatments for chronic and life-threatening human diseases based on its gene silencing therapy, DNA-directed RNA interference in Australia and the United States. The company has market cap of $27.18 million. The firm provides BB-301, a single administration ddRNAi gene therapy for the treatment of oculopharyngeal muscular dystrophy; BB-201, a ddRNAi therapy for the treatment of wet age-related macular degeneration; and BB-101 and BB-103 ddRNAi therapies for the treatment of human hepatitis B. It currently has negative earnings. It also offers BB-401 and BB-501 for the treatment of oncology.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: